September 9, 2021 Boston Scientific Corporation reported that it will host a meeting with the investor community to review its financial goals and long-term growth strategies on Wednesday, September 22, 2021, from 8:30 a.m. – 12:30 p.m. EDT (Press release, Boston Scientific, SEP 9, 2021, View Source [SID1234587476]). Company leaders will also provide business unit market overviews, pipeline updates and spotlight key products from the company’s Cardiovascular, MedSurg and Rhythm and Neuro segments.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The meeting will be held in hybrid format, live in Boston as well as a simultaneous webcast. Investors and other interested parties may register for the live meeting or webcast by visiting the events and presentations section on the company’s investor website at View Source A replay and summary materials from the presentations will also be available online for approximately one year following the event.